HPA008612

antibody from Atlas Antibodies

Targeting: TGFBI BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

HPA008612

Provider

Atlas Antibodies

Proper citation

Atlas Antibodies Cat#HPA008612, RRID:AB_1857970

Product name

Anti-TGFBI

Antibody type

Polyclonal

Description

Polyclonal Antibody against Human TGFBI, Gene description: transforming growth factor, beta-induced, 68kDa, Alternative Gene Names: BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1, Validated applications: IHC, Uniprot ID: Q15582, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

100 µl

Concentration

0.1 mg/ml

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Handling

The antibody solution should be gently mixed before use.

References

Submitted references

Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer.

Sköld C, Corvigno S, Dahlstrand H, Enblad G, Mezheyeuski A, Sundström-Poromaa I, Stålberg K, Tolf A, Glimelius I, Koliadi A
Cancer causes & control : CCC 2024 Aug;35(8):1101-1109

---

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness.

Li Y, Lih TM, Dhanasekaran SM, Mannan R, Chen L, Cieslik M, Wu Y, Lu RJ, Clark DJ, Kołodziejczak I, Hong R, Chen S, Zhao Y, Chugh S, Caravan W, Naser Al Deen N, Hosseini N, Newton CJ, Krug K, Xu Y, Cho KC, Hu Y, Zhang Y, Kumar-Sinha C, Ma W, Calinawan A, Wyczalkowski MA, Wendl MC, Wang Y, Guo S, Zhang C, Le A, Dagar A, Hopkins A, Cho H, Leprevost FDV, Jing X, Teo GC, Liu W, Reimers MA, Pachynski R, Lazar AJ, Chinnaiyan AM, Van Tine BA, Zhang B, Rodland KD, Getz G, Mani DR, Wang P, Chen F, Hostetter G, Thiagarajan M, Linehan WM, Fenyö D, Jewell SD, Omenn GS, Mehra R, Wiznerowicz M, Robles AI, Mesri M, Hiltke T, An E, Rodriguez H, Chan DW, Ricketts CJ, Nesvizhskii AI, Zhang H, Ding L, Clinical Proteomic Tumor Analysis Consortium
Cancer cell 2023 Jan 9;41(1):139-163.e17

---

TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.

Zhu J, Chen X, Liao Z, He C, Hu X
International journal of clinical and experimental pathology 2015;8(1):702-10

---

SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome

Kashyap M, Harsha H, Renuse S, Pawar H, Sahasrabuddhe N, Kim M, Marimuthu A, Keerthikumar S, Muthusamy B, Kandasamy K, Subbannayya Y, Prasad T, Mahmood R, Chaerkady R, Meltzer S, Kumar R, Rustgi A, Pandey A
Cancer Biology & Therapy 2014;10(8):796-810

---

Association of TCF4 and CLU polymorphisms with Fuchs’ endothelial dystrophy and implication of CLU and TGFBI proteins in the disease process

Kuot A, Hewitt A, Griggs K, Klebe S, Mills R, Jhanji V, Craig J, Sharma S, Burdon K
European Journal of Human Genetics 2012;20(6):632-638

Immunohistochemistry

Supportive validation

Submitted by

Atlas Antibodies (provider)

Enhanced method

Orthogonal validation

Main image

Experimental details

Immunohistochemistry analysis in human placenta and pancreas tissues using HPA008612 antibody. Corresponding TGFBI RNA-seq data are presented for the same tissues.

Sample type

Human

Protocol

Protocol

Orthogonal method

Orthogonal validation of protein expression using IHC by comparison to RNA-seq data of corresponding target in high and low expression tissues.

Show more